Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.

NTI

ASX:NTI

Neurotech International Limited

Last Close

0.05

08/11 03:27

Market Cap

85.46M

Beta: 2.02

Volume Today

629.52K

Avg: 466.79K

PE Ratio

−10.61

PFCF: −13.56

locale

market

industry

website

ipo date

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics